Literature DB >> 8784788

AIDS dementia is associated with massive, activated HIV-1 infection and concomitant expression of several cytokines.

G J Nuovo1, M L Alfieri.   

Abstract

BACKGROUND: We recently showed that acquired immunodeficiency syndrome (AIDS) dementia is associated with activated infection of microglia, neurons, and astrocytes by HIV-1. However, it is doubtful whether infection per se is responsible for the dramatic symptoms associated with AIDS dementia. The purpose of this study was to determine the histologic distribution of messenger RNAs (mRNAs) of several cytokines that have been implicated in AIDS pathogenesis and to correlate this expression pattern with the in situ localization of polymerase chain reaction (PCR)-amplified HIV-1 nucleic acids in the central nervous system (CNS).
MATERIALS AND METHODS: HIV-1 DNA was detected by PCR in situ hybridization. HIV-1 RNA and cytokine expression, including tumor necrosis factor alpha (TNF), inducible nitric oxide synthetase (iNOS), and macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta mRNA were detected by reverse transcriptase (RT) in situ PCR.
RESULTS: Amplified viral DNA was detected in each of the seven HIV-1-positive cases and in none of the five negative controls. In people with AIDS dementia, many HIV-1 DNA-positive cells were detected in regions of the CNS that corresponded to clinical symptomatology. In AIDS patients with minimal CNS involvement, rare HIV-1-infected microglial cells were noted. Viral RNA was detected primarily in cases of AIDS dementia. TNF, iNOS, MIP-1 alpha and MIP-1 beta expression localized to tissues from AIDS dementia cases where HIV-1 infected cells were plentiful. Colocalization experiments showed that these cytokines were transcribed mostly by viral-negative cells.
CONCLUSIONS: These results suggest that two key elements in AIDS dementia are massive productive viral infection, involving microglia, neurons, and astrocytes, and concomitant stimulation of cytokine transcription in the neighboring uninfected cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8784788      PMCID: PMC2230156     

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  18 in total

1.  A quantitative reverse transcriptase-polymerase chain reaction for HIV-1-specific RNA species.

Authors:  T Seshamma; O Bagasra; J W Oakes; R J Pomerantz
Journal:  J Virol Methods       Date:  1992-12-01       Impact factor: 2.014

2.  Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures.

Authors:  V L Dawson; T M Dawson; E D London; D S Bredt; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

3.  Human immunodeficiency virus type 1 infection of neural xenografts.

Authors:  T A Cvetkovich; E Lazar; B M Blumberg; Y Saito; T A Eskin; R Reichman; D A Baram; C del Cerro; H E Gendelman; M del Cerro
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

Review 4.  HIV-related neurotoxicity.

Authors:  S A Lipton
Journal:  Brain Pathol       Date:  1991-04       Impact factor: 6.508

5.  Specific tropism of HIV-1 for microglial cells in primary human brain cultures.

Authors:  B A Watkins; H H Dorn; W B Kelly; R C Armstrong; B J Potts; F Michaels; C V Kufta; M Dubois-Dalcq
Journal:  Science       Date:  1990-08-03       Impact factor: 47.728

6.  Detection of human immunodeficiency virus type 1 provirus in mononuclear cells by in situ polymerase chain reaction.

Authors:  O Bagasra; S P Hauptman; H W Lischner; M Sachs; R J Pomerantz
Journal:  N Engl J Med       Date:  1992-05-21       Impact factor: 91.245

7.  Human immunodeficiency virus type 1 expression in the central nervous system correlates directly with extent of disease.

Authors:  B Weiser; N Peress; D La Neve; D J Eilbott; R Seidman; H Burger
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

8.  Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta.

Authors:  C Tornatore; A Nath; K Amemiya; E O Major
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

9.  In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-alpha RNA in the central nervous system.

Authors:  G J Nuovo; F Gallery; P MacConnell; A Braun
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

10.  Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide.

Authors:  J M Harouse; S Bhat; S L Spitalnik; M Laughlin; K Stefano; D H Silberberg; F Gonzalez-Scarano
Journal:  Science       Date:  1991-07-19       Impact factor: 47.728

View more
  45 in total

1.  Critical role of nitric oxide during the apoptosis of peripheral blood leukocytes from patients with AIDS.

Authors:  M D Mossalayi; P A Becherel; P Debré
Journal:  Mol Med       Date:  1999-12       Impact factor: 6.354

Review 2.  Virus receptors in the human central nervous system.

Authors:  B Schweighardt; W J Atwood
Journal:  J Neurovirol       Date:  2001-06       Impact factor: 2.643

3.  Cytochrome C dysregulation induced by HIV infection of astrocytes results in bystander apoptosis of uninfected astrocytes by an IP3 and calcium-dependent mechanism.

Authors:  Eliseo A Eugenin; Joan W Berman
Journal:  J Neurochem       Date:  2013-10-20       Impact factor: 5.372

4.  Mechanism of HIV-1-TAT induction of interleukin-1beta from human monocytes: Involvement of the phospholipase C/protein kinase C signaling cascade.

Authors:  Yongbo Yang; Jianguo Wu; Yuanan Lu
Journal:  J Med Virol       Date:  2010-05       Impact factor: 2.327

Review 5.  Role of microglia in central nervous system infections.

Authors:  R Bryan Rock; Genya Gekker; Shuxian Hu; Wen S Sheng; Maxim Cheeran; James R Lokensgard; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 6.  Biomarkers for neuroAIDS: the widening scope of metabolomics.

Authors:  Gurudutt Pendyala; Elizabeth J Want; William Webb; Gary Siuzdak; Howard S Fox
Journal:  J Neuroimmune Pharmacol       Date:  2006-10-10       Impact factor: 4.147

Review 7.  Large animal models of neurological disorders for gene therapy.

Authors:  Christine Gagliardi; Bruce A Bunnell
Journal:  ILAR J       Date:  2009

Review 8.  Benzodiazepines, glia, and HIV-1 neuropathogenesis.

Authors:  J R Lokensgard; C C Chao; G Gekker; S Hu; P K Peterson
Journal:  Mol Neurobiol       Date:  1998-08       Impact factor: 5.590

Review 9.  Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND.

Authors:  Peter J Gaskill; Tina M Calderon; Jacqueline S Coley; Joan W Berman
Journal:  J Neuroimmune Pharmacol       Date:  2013-03-01       Impact factor: 4.147

10.  Pro-inflammatory functions of astrocytes correlate with viral clearance and strain-dependent protection from TMEV-induced demyelinating disease.

Authors:  Pamela A Carpentier; Meghann Teague Getts; Stephen D Miller
Journal:  Virology       Date:  2008-03-04       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.